MOTS-C (Mitochondrial-Derived Peptide)
Synthetic Mitochondrial-Derived Peptide | Metabolic, Cellular Energy & AMPK Signaling Studies
₱2100.00₱1600.00
BUY NOW |
|---|
Third-party Tested | Free Shipping Nationwide | COA Verified |
Active Batch | Purity |
MOTS-SL6P44-10 | > 99.7% |
All products are third-party tested by our manufacturer before release and are submitted again to an independent third-party laboratory upon arrival in the Philippines. This additional testing helps verify identity, purity, heavy metals, residual solvents, microbial safety, and overall batch quality before distribution. If independent testing shows purity below 99%, we offer a money-back guarantee.
MOTS-C is an investigational synthetic peptide commonly discussed in research settings for its relationship to mitochondrial signaling, metabolic regulation, cellular energy balance, AMPK pathway activity, insulin-sensitivity models, exercise-mimetic research, and healthy-aging investigation. It is commonly described as a mitochondrial-derived peptide associated with the mitochondrial open reading frame of the 12S rRNA-c, a small peptide sequence studied for its role in cellular stress response, metabolic adaptation, and energy-homeostasis pathways.
Unlike tissue-repair peptides such as TB-500 or BPC-157, MOTS-C is not primarily designed around connective-tissue remodeling, actin regulation, tendon research, or wound-healing models. Unlike GH secretagogues such as Ipamorelin, CJC-1295, Tesamorelin, or Sermorelin, MOTS-C is not primarily studied for growth-hormone release or GH/IGF-1 axis stimulation. Instead, scientific interest centers on mitochondrial communication, AMPK activation, glucose-utilization research, insulin-signaling models, metabolic flexibility, exercise-mimetic pathways, cellular stress adaptation, and broader metabolic-health investigation.
MOTS-C is frequently discussed in peptide research communities alongside other metabolic and longevity-oriented compounds because of its connection to mitochondrial function and cellular energy regulation. Research interest is generally focused on metabolic signaling and mitochondrial-derived peptide biology rather than direct hormone modulation, appetite suppression, or tissue-repair targeting.
Potential research interests observed in studies
Metabolic-health research
MOTS-C is widely discussed for its relationship to metabolic-health models, especially research involving glucose utilization, energy balance, insulin signaling, and substrate metabolism. Scientific interest often centers on how mitochondrial-derived peptides may influence adaptive metabolic pathways in controlled research settings.
AMPK signaling research
A key area of MOTS-C research involves AMPK signaling. AMPK is an important cellular energy-sensing pathway involved in metabolic regulation, glucose uptake, fatty-acid oxidation, and cellular stress response. MOTS-C is commonly discussed in relation to AMPK pathway activity, which makes it a peptide of interest in metabolic and cellular-energy research.
Insulin-sensitivity and glucose-utilization research
MOTS-C is frequently associated with insulin-sensitivity and glucose-metabolism research. In peptide research communities, it is often discussed for its potential relevance to models involving glucose uptake, insulin signaling, metabolic flexibility, and energy-homeostasis pathways. These areas should be framed as investigational research interests rather than confirmed therapeutic outcomes.
Mitochondrial function and cellular-energy models
Because MOTS-C is classified as a mitochondrial-derived peptide, it is often discussed in research models involving mitochondrial communication, cellular energy regulation, oxidative stress response, and metabolic adaptation. Scientific interest may include mitochondrial signaling, cellular resilience, and energy-production pathway investigation.
Exercise-mimetic research
MOTS-C is commonly discussed in research involving exercise-mimetic pathways, or biological signaling patterns that overlap with certain exercise-associated metabolic adaptations. This area of interest is related to AMPK activity, endurance models, glucose handling, and cellular stress-response research.
Healthy-aging investigation
MOTS-C is often studied or discussed in relation to aging biology and cellular resilience models. Research interest may include mitochondrial stress response, age-associated metabolic changes, cellular adaptation, and pathways connected to metabolic healthspan. These discussions should remain research-focused and should not be presented as proven anti-aging claims.
Body-composition and metabolic-flexibility research
MOTS-C is frequently discussed in peptide research communities for its possible relationship to body-composition models, substrate utilization, energy expenditure, and metabolic flexibility. This interest is commonly connected to broader mitochondrial and AMPK-related signaling research rather than direct fat-loss or muscle-growth claims.
Performance and endurance research
In research-oriented discussions, MOTS-C is often associated with endurance models, exercise adaptation, cellular energy availability, and performance-support investigation. These should be described as research interests, not approved claims for athletic enhancement, stamina improvement, or physical performance outcomes.
Cellular stress and inflammation-response interest
Because mitochondrial signaling is closely connected to cellular stress pathways, MOTS-C is sometimes discussed in relation to oxidative stress, inflammatory signaling, and cellular-protection models. These areas remain investigational and should not be framed as guaranteed anti-inflammatory, protective, or regenerative outcomes.
Limitations and risks observed or discussed
Unknown long-term safety for unapproved use
Long-term safety, dose-response, interaction risks, risk groups, and appropriate monitoring are not fully established for unapproved or research-grade use outside regulated clinical settings. MOTS-C should be discussed as an investigational research compound, not as an approved therapeutic product.
Metabolic and glucose-regulation concerns
Because MOTS-C is commonly discussed in relation to glucose utilization, insulin signaling, AMPK activity, and metabolic regulation, inappropriate use may raise concerns around unexpected metabolic changes, altered glucose handling, or risks in settings involving metabolic disease, medication interactions, or impaired energy regulation. These concerns should be considered in research design and interpretation.
Cellular-stress and mitochondrial-pathway considerations
Research involving mitochondrial signaling, AMPK activation, oxidative stress, or cellular adaptation can be complex. Outcomes may vary depending on model type, study duration, concentration, route of exposure, biological context, and baseline metabolic status.
Lack of approved clinical-use framework
MOTS-C does not have the same established clinical-use framework as approved medications. Claims around fat loss, glucose control, endurance, anti-aging, mitochondrial enhancement, insulin sensitivity, or metabolic improvement should not be overstated or presented as established outcomes.
Website-safe closing line
MOTS-C is scientifically interesting for mitochondrial-derived peptide research, AMPK signaling, cellular-energy regulation, glucose-utilization models, insulin-sensitivity research, metabolic-flexibility studies, exercise-mimetic pathways, cellular stress-response models, and healthy-aging investigation. While research around MOTS-C is promising in specific controlled contexts, broad claims around fat loss, blood sugar control, athletic performance, endurance, anti-aging, mitochondrial enhancement, or disease treatment should not be overstated. MOTS-C should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.
MOTS-c Protects Against Placental Injury via Nrf2 Activation | MOTS-c Attenuates Mitochondrial Dysfunction & Pyroptosis in Osteoarthritis |
